Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection - Implications for development of a possible diagnostic marker

Transplant Immunology

Volumn 15, Issue 2, 2005, Pages 165-172

  Osterholm C ^a   Veress, B ^a   Simanaitis, M ^a   Hedner, U ^b   Ekberg, H ^a  

^a LUND UNIVERSITY   (Sweden)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Acute rejection; Calcineurin inhibitor; Chronic rejection; Nephrotoxicity; Tissue factor

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CYCLOSPORIN A; THROMBOPLASTIN;

ACUTE GRAFT REJECTION; ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY STRUCTURE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; BLOOD COAGULATION; CALCINEURIN; CHRONIC DISEASE; CYCLOSPORINE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; RABBITS; THROMBOPLASTIN;

EID: 30444433563     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2005.06.001     Document Type: Article

References (34)

1. J.K. Connolly, P.A. Dyer, S. Martin, N.R. Parrott, R.C. Pearson, and R.W. Johnson Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation Transplantation 15 1996 (Mar 15) 709 714
2. C. Pouteil-Noble, R. Ecochard, G. Landrivon, A. Donia-Maged, J.C. Tardy, and S. Bosshard Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients Transplantation 55 1993 851 857
3. B.J. Nankivell, R.J. Borrows, C.L. Fung, P.J. O'Connell, R.D. Allen, and J.R. Chapman The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326 2333
4. B.J. Nankivell, R.J. Borrows, C.L. Fung, P.J. O'Connell, J.R. Chapman, and R.D. Allen Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology Transplantation 78 2004 557 565
5. K. Solez, R.A. Axelsen, H. Benediktsson, J.F. Burdick, A.H. Cohen, and R.B. Colvin International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology Kidney Int 44 1993 (Aug) 411 422
6. T.A. Drake, J.H. Morrissey, and T.S. Edgington Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis Am J Pathol 134 1989 (May) 1087 1097
7. M.E. Bromberg, R. Sundaram, R.J. Homer, A. Garen, and W.H. Konigsberg Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule Thromb Haemost 82 1999 (Jul) 88 92
8. F. Mach, U. Schonbeck, J.Y. Bonnefoy, J.S. Pober, and P. Libby Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor Circulation 96 1997 396 399
9. M. Belting, M.I. Dorrell, S. Sandgren, E. Aguilar, J. Ahamed, and A. Dorfleutner Regulation of angiogenesis by tissue factor cytoplasmic domain signaling Nat Med 10 2004 502 509
10. J.H. Erlich, E.M. Boyle, J. Labriola, J.C. Kovacich, R.A. Santucci, and C. Fearns Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation Am J Pathol 157 2000 (Dec) 1849 1862
11. F.B. Taylor, A.C. Chang, G. Peer, A. Li, M. Ezban, and U. Hedner Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli Blood 91 1998 (Mar 1) 1609 1615
12. C.T. Esmon Inflammation and thrombosis J Thromb Haemost 1 2003 1343 1348
13. T.A. Drake, J.H. Morrissey, and T.S. Edgington Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis Am J Pathol 134 1989 1087 1097
14. A. Bukovsky, C.A. Labarrere, B. Haag, C. Carter, and W.P. Faulk Tissue factor in normal and transplanted human kidneys Transplantation 54 1992 (Oct) 644 650
15. C. Flossel, T. Luther, M. Muller, S. Albrecht, and M. Kasper Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue Histochemistry 101 1994 449 453
16. S. Siegel, and N.J. Castellan Nonparametric statistics for the behavioral sciences 2nd ed. 1988 McGraw-Hill Inc. New York
17. Y. Dorffel, G. Wallukat, N. Bochnig, V. Homuth, M. Herberg, and W. Dorffel Agonistic AT(1) receptor autoantibodies and monocyte stimulation in hypertensive patients Am J Hypertens 16 2003 827 833
18. 2+ mobilization and protein kinase C activation J Clin Invest 91 1993 547 552
19. Y. Kunieda, K. Nakagawa, H. Nishimura, H. Kato, N. Ukimura, and S. Yano HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells Thromb Res 110 2003 227 234
20. D.B. Lee Cyclosporine and the renin-angiotensin axis Kidney Int 52 1997 248 260
21. I.V. Hutchinson An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs Curr Opin Nephrol Hypertens 7 1998 665 671
22. A.S. Sethi, D.M. Lees, J.A. Douthwaite, and R. Corder Factor VIIa stimulates endothelin-1 synthesis in TNF-primed endothelial cells by activation of protease-activated receptor 2 Clin Sci (Lond) 108 2005 255 263
23. A. Gorlach, R.P. Brandes, S. Bassus, N. Kronemann, C.M. Kirchmaier, and R. Busse Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets FASEB J 14 2000 1518 1528
24. M.P. Bevilacqua, J.S. Pober, G.R. Majeau, W. Fiers, R.S. Cotran, and M.A.J. Gimbrone Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 Proc Natl Acad Sci U S A 83 1986 (Jun) 4533 4537
25. R.J. Torry, C.A. Labarrere, D. Nelson, C. Carter, B. Haag, and W.P. Faulk Tubular antithrombin at transplantation determines subsequent renal allograft function Transplantation 66 1998 797 799
26. A. Tsuchida, H. Salem, N. Thomson, and W.W. Hancock Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression J Exp Med 175 1992 81 90
27. R.J. Torry, C.A. Labarrere, P. Gargiulo, and W.P. Faulk Natural anticoagulant and fibrinolytic pathways in renal allograft failure Transplantation 58 1994 926 931
28. Y. Wang, J.R. Pratt, B. Hartley, B. Evans, L. Zhang, and S.H. Sacks Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure Kidney Int 52 1997 371 377
29. C. Osterholm, Z. Qi, J. Ekberg, B. Veress, C. Pyke, and U. Hedner Initial inhibition of tissue factor signalling reduces chronic vascular changes in isogenic rat aortic transplants Am J Transplant 1 2001 (May) 29 37
30. Y. Jang, L.A. Guzman, A.M. Lincoff, M. Gottsauner-Wolf, F. Forudi, and C.E. Hart Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model Circulation 92 1995 3041 3050
31. B.A. Lwaleed, M. Chisholm, and J.L. Francis Urinary tissue factor levels in patients with breast and colorectal cancer J Pathol 187 1999 291 294
32. B.A. Lwaleed, J.L. Francis, and M. Chisholm Urinary tissue factor levels in patients with bladder and prostate cancer Eur J Surg Oncol 26 2000 44 49
33. B.A. Lwaleed, P.S. Bass, and J.L. Francis Urinary tissue factor: a potential marker of disease J Pathol 188 1999 3 8
34. M. Matsuda, N. Aoki, and A. Kawaoi Localization of urinary procoagulant in the human kidney Kidney Int 15 1979 612 617